Aprea Therapeutics to Present Data from Clinical Trials Evaluating Eprenetapopt at 63rd American Society of Hematology Annual Meeting $APRE https://t.co/DEyAsYRmHP
@AgInAustin1@slfairless No, he isn't. These 2 companies have the same CEO. He evaluated lots of projects but he failed and he merged with himself. That's ridiculous, cmon.